Similar articles for PMID: 20473155

Year	Number of Results
1999	1
2000	2
2001	2
2003	1
2004	2
2005	3
2006	5
2007	2
2008	6
2009	6
2010	9
2011	6
2012	6
2013	9
2014	7
2015	10
2016	12
2017	8
2018	5
2019	6
2020	13
2021	10
2022	10
2023	4
2024	0

1

Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies.

Burckart K, Beca S, Urban RJ, Sheffield-Moore M. Burckart K, et al. Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):410-6. doi: 10.1097/MCO.0b013e328339fdd2. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20473155 Free PMC article. Review.

2

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ. Zhou X, et al. Cell. 2010 Aug 20;142(4):531-43. doi: 10.1016/j.cell.2010.07.011. Cell. 2010. PMID: 20723755 Free article.

3

Inflammatory burden and amino acid metabolism in cancer cachexia.

Durham WJ, Dillon EL, Sheffield-Moore M. Durham WJ, et al. Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):72-7. doi: 10.1097/MCO.0b013e32831cef61. Curr Opin Clin Nutr Metab Care. 2009. PMID: 19057191 Free PMC article. Review.

4

Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.

Bowen TS, Adams V, Werner S, Fischer T, Vinke P, Brogger MN, Mangner N, Linke A, Sehr P, Lewis J, Labeit D, Gasch A, Labeit S. Bowen TS, et al. J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):939-953. doi: 10.1002/jcsm.12233. Epub 2017 Sep 8. J Cachexia Sarcopenia Muscle. 2017. PMID: 28887874 Free PMC article.

5

F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.

Sukari A, Muqbil I, Mohammad RM, Philip PA, Azmi AS. Sukari A, et al. Semin Cancer Biol. 2016 Feb;36:95-104. doi: 10.1016/j.semcancer.2016.01.002. Epub 2016 Jan 21. Semin Cancer Biol. 2016. PMID: 26804424 Free PMC article. Review.

6

Ghrelin: from discovery to cancer cachexia therapy.

Molfino A, Formiconi A, Rossi Fanelli F, Muscaritoli M. Molfino A, et al. Curr Opin Clin Nutr Metab Care. 2014 Sep;17(5):471-6. doi: 10.1097/MCO.0000000000000075. Curr Opin Clin Nutr Metab Care. 2014. PMID: 24905862 Review.

7

Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.

Dalton JT, Taylor RP, Mohler ML, Steiner MS. Dalton JT, et al. Curr Opin Support Palliat Care. 2013 Dec;7(4):345-51. doi: 10.1097/SPC.0000000000000015. Curr Opin Support Palliat Care. 2013. PMID: 24189892 Review.

8

Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.

Miyamoto Y, Hanna DL, Zhang W, Baba H, Lenz HJ. Miyamoto Y, et al. Clin Cancer Res. 2016 Aug 15;22(16):3999-4004. doi: 10.1158/1078-0432.CCR-16-0495. Epub 2016 Jun 23. Clin Cancer Res. 2016. PMID: 27340276 Free PMC article. Review.

9

Mechanism and novel therapeutic approaches to wasting in chronic disease.

Ebner N, Springer J, Kalantar-Zadeh K, Lainscak M, Doehner W, Anker SD, von Haehling S. Ebner N, et al. Maturitas. 2013 Jul;75(3):199-206. doi: 10.1016/j.maturitas.2013.03.014. Epub 2013 May 9. Maturitas. 2013. PMID: 23664695 Review.

10

Pathophysiology of peripheral muscle wasting in cardiac cachexia.

Filippatos GS, Anker SD, Kremastinos DT. Filippatos GS, et al. Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54. doi: 10.1097/01.mco.0000165002.08955.5b. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15809526 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year